Work

Shorter Duration of Blinatumomab Administration to 14 Days Has Same Efficacy and Safety Profile in Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia: A Retrospective Single‐Center Study

Year: 2024

Type: article

Study design: Observational Study

Source: Acta Haematologica

DOI: 10.1159/000542060

Authors: Jinyu Kong, Wenjing Miao, Jialing Lu, Yin Liu, Xin Kong, Huiying Qiu, Baoquan Song

Institutions: First Affiliated Hospital of Soochow University, Shanghai Traditional Chinese Medicine Hospital, Soochow University, Nanchang University, First Affiliated Hospital of Jiangxi Medical College, First Affiliated Hospital of Nanchang University

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403814793

FWCI: 0.384

Cites: 17

Cited by: 1

Related to: 10